The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
dihydroactinidiolide inhibits the reaction [Colchicine results in increased activity of ACHE protein]; dihydroactinidiolide inhibits the reaction [Glutamic Acid results in increased activity of ACHE protein] dihydroactinidiolide inhibits the reaction [Scopolamine results in increased activity of ACHE protein]
dihydroactinidiolide inhibits the reaction [amyloid beta-protein (25-35) results in increased expression of BAX protein]; dihydroactinidiolide inhibits the reaction [Colchicine results in increased expression of BAX protein]; dihydroactinidiolide inhibits the reaction [Dithionite results in increased expression of BAX protein]; dihydroactinidiolide inhibits the reaction [Glutamic Acid results in increased expression of BAX protein] dihydroactinidiolide inhibits the reaction [Scopolamine results in increased expression of BAX protein]
dihydroactinidiolide inhibits the reaction [amyloid beta-protein (25-35) results in decreased expression of BCL2 protein]; dihydroactinidiolide inhibits the reaction [Colchicine results in decreased expression of BCL2 protein]; dihydroactinidiolide inhibits the reaction [Dithionite results in decreased expression of BCL2 protein]; dihydroactinidiolide inhibits the reaction [Glutamic Acid results in decreased expression of BCL2 protein] dihydroactinidiolide inhibits the reaction [Scopolamine results in decreased expression of BCL2 protein]
dihydroactinidiolide inhibits the reaction [amyloid beta-protein (25-35) results in increased activity of CASP3 protein]; dihydroactinidiolide inhibits the reaction [amyloid beta-protein (25-35) results in increased expression of CASP3 protein]; dihydroactinidiolide inhibits the reaction [Colchicine results in increased activity of CASP3 protein]; dihydroactinidiolide inhibits the reaction [Colchicine results in increased expression of CASP3 protein]; dihydroactinidiolide inhibits the reaction [Glutamic Acid results in increased expression of CASP3 protein] dihydroactinidiolide inhibits the reaction [Scopolamine results in increased activity of CASP3 protein]
[dihydroactinidiolide co-treated with amyloid beta-protein (25-35)] results in increased expression of HMOX1 mRNA; [dihydroactinidiolide co-treated with Colchicine] results in increased expression of HMOX1 mRNA; [dihydroactinidiolide co-treated with Dithionite] results in increased expression of HMOX1 mRNA; [dihydroactinidiolide co-treated with Glutamic Acid] results in increased expression of HMOX1 mRNA
[dihydroactinidiolide co-treated with amyloid beta-protein (25-35)] results in increased expression of NFE2L2 mRNA; [dihydroactinidiolide co-treated with Colchicine] results in increased expression of NFE2L2 mRNA; [dihydroactinidiolide co-treated with Dithionite] results in increased expression of NFE2L2 mRNA; [dihydroactinidiolide co-treated with Glutamic Acid] results in increased expression of NFE2L2 mRNA
browse the term
